Latest Breaking News On - Huntington disease - Page 2 : comparemela.com

Prilenia Therapeutics B.V.: Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024

'Paddle for a cure' pickleball tournament in Woodbury on Saturday

The Huntington Disease Society of America’s Minnesota Chapter will be hosting a charity pickleball event Saturday at Legacy Pickleball Club, 2122 Wooddale Drive, in Woodbury. The Pickleball Tournament & Fun event is a family-oriented event aiming to “paddle for a cure,” with educational opportunities to learn more about Huntington’s disease and HDSA’s work. Huntington’s disease is a fatal .

Nakasone Award Goes to Pioneer in Sleep, Brain Health Research

Maiken Nedergaard received the award for her discoveries about the glymphatic system, improving the understanding of sleep and brain health.

Alterity Therapeutics : Target Market Determination (TMD) for the placement options offered under the Company's prospectus dated 29 December 2023 -December 28, 2023 at 10:42 pm EST

Target Market Determination for the placement options offered under the Company s prospectus dated 29 December 2023 December 29, 2023December 29, 2023 Alterity.

Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Capsules Data Demonstrating Early and Sustained Improvements in Chorea Associated With Huntington's Disease

/PRNewswire/ Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data on now FDA-approved INGREZZA® (valbenazine) capsules for the treatment of.